Published date: 22 December 2016

Last edited date: 22 December 2016

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 1 April 2016

Contract summary

Industry

  • General anti-infectives for systemic use and vaccines - 33651000

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

CM/PHV/12/5356

Published date

22 December 2016

Closing date

1 April 2016

Contract start date

1 April 2017

Contract end date

31 March 2019

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib) to be used as part of the national childhood immunisation programme, deliveries will be required from 1 April 2017 to 31 March 2019, with an option to extend for up to an additional 24 months

More information

Attachments

Award information

Awarded date

16 August 2016

Contract start date

1 April 2017

Contract end date

31 March 2019

Total value of contract

£0

This contract was awarded to 1 supplier.

GlaxoSmithKline UK Ltd

Address

980 Great West Road
Brentford
TW8 9GS

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Additional details

This supplier is not an SME

About the buyer

Address

2nd Floor
Rutland House
Runcorn
WA7 2ES
England

Email

lynne.nichols@dh.gsi.gov.uk